Beam Therapeutics Inc.
NASDAQBeam Therapeutics heads into mid-May with its short sellers in full retreat — and a string of data catalysts lined up that could test how far that retreat goes. Short interest has dropped sharply over the past three weeks. It came down from a peak of roughly 27% of the free float in mid-April to 23% today — a decline of around four percentage points, with the sharpest single-week…
Snapshot as of 28 Jun 2026
Beam Therapeutics heads into mid-May with its short sellers in full retreat — and a string of data catalysts lined up that could test how far that retreat goes. Short interest has dropped sharply over the past three…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BEAM — free to start on ORTEX.
Sign up for free →Open BEAM on ORTEX